Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PRF vs H-PRF vs Stent for Palatal Donor Site Healing
NCT04758702Phase 1Completed
- Start
- Feb 2021
- Primary completion
- May 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of platelet rich fibrin and horizontal platelet-rich fibrin in surgical wound (3 arms). Primary endpoint: Percentage of Re-epithelization of the Palatal Donor Site at 21 days. Started Feb 2021; status: completed.
02
Drugs
platelet rich fibrinhorizontal platelet-rich fibrin
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT04758702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04758702.